AI
Healthcare & Life Sciences
ai3Bio
United Statesai3.bio
ai3Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About ai3Bio
ai3Bio is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Develops biotechnology therapeutics that selectively eliminate disease-causing T cells to treat autoimmune diseases using LNP/mRNA and antibody-based platforms targeting pathogenic Th17 and other inflammatory T cells.
Explore ai3Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.